Pakistan seen as hot pharma growth market
01 June 2015
Some of the Asia-Pacific region's major countries can expect continued increases in pharmaceutical expenditures during the third quarter, led, surprisingly, by Pakistan.
Quintiles homes in on Asian biotech with its latest offering
01 June 2015
Quintiles, the world's largest CRO, is targeting the growing number of small and midsize biotech companies in Asia, porting its bespoke offering to the region in hopes of partnering with the continent's up-and-coming drug developers.
IPR challenge could up the ante of defending drug patents
29 May 2015
Defending patents for drugs and medical devices is part of the stakes of an R&D budget, but the size of that stake could increase significantly if a hedge fund manager wins his inter partes review (IPR) challenge of selected drug patents.
CROs/CMOs Powering Vaccine R&D At Biotechs
29 May 2015
The first is about vaccine shortages and cutting R&D investment. Chacón’s is a positive tale of a growing number of startups and biotechs utilizing CROs/CMOs to create a new R&D industry for innovative vaccines. The antagonists in the first case – placing price ahead of access and free-markets – are the very organizations Chacón lionizes above.
New Push Ties Cost of Drugs to How Well They Work
29 May 2015
Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.
Russia gives green light to parallel imports in bid to lower prices
29 May 2015
The Russian government has given its approval to parallel imports, meaning that it will be possible to import some goods for sale in Russia without rights holder permission. The government hopes that this decision will lead to a drop in prices, but experts say that its major consequence will be an increase in counterfeit goods. Moreover, the measure is contrary to the norms of the Eurasian Economic Union, the key integration union on the territory of the former USSR.
Russia makes it easier to skirt imported drug sale norms
28 May 2015
Moscow is opening a gray market to allow imports of drugs intended for sale in other countries to be sold in Russia without the consent of the maker with a trademark for the product. The government hopes the move will lower pharmaceutical costs.
Starting antiretroviral treatment early improves outcomes for HIV-infected individuals
28 May 2015
A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together with data from previous studies showing that antiretroviral treatment reduced the risk of HIV transmission to uninfected sexual partners, these findings support offering treatment to everyone with HIV.
Singapore moving to meet pharma manufacturing demand for high-quality water
27 May 2015
Singapore, like other Asian countries looking to woo pharmaceutical manufacturers, is moving quickly to meet increasing demand for high-quality water required by strict regulations in the U.S. and European Union.
EU's medicines agency stands by recommendation to suspend drugs studied at GVK India facility
27 May 2015
The European Medicines Agency is standing by its original recommendation made earlier this year to suspend a number of medicines that received European Union clearance based on clinical studies conducted by GVK Biosciences in India.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024